Related Experiment Video
Updated: May 13, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Immune cell dysfunction and inflammation in end-stage renal disease
1Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus Medical Centre, Rotterdam, The Netherlands. m.g.h.betjes@erasmusmc.nl
Uraemia in end-stage renal disease (ESRD) impairs immune function and accelerates aging, increasing cancer and infection risks. This immune aging persists even after kidney transplantation, suggesting stem cell alterations.
Area of Science:
- Nephrology
- Immunology
- Cardiovascular Medicine
Background:
- Uraemia in end-stage renal disease (ESRD) is linked to immune dysfunction, including increased cancer risk, infections, and poor vaccine response.
- Uraemia-associated inflammation likely contributes to the high atherosclerosis risk in ESRD patients.
- ESRD patients exhibit reduced lymphoid cells but normal/increased myeloid cells, with elevated inflammatory cytokines and reactive oxygen species.
Purpose of the Study:
- To investigate the impact of uraemia on immune system function and cellular composition in end-stage renal disease (ESRD) patients.
- To explore the concept of premature immunological aging in ESRD and its potential link to cardiovascular risk factors.
- To determine if immune system cellular composition normalizes after kidney transplantation.
Main Methods:
- Comparative analysis of immune cell populations (lymphoid vs. myeloid) and their functions in uraemic patients versus healthy controls.
- Assessment of inflammatory markers, cytokines, and reactive oxygen species in ESRD.
- Evaluation of immune cell composition and inflammatory status in ESRD patients pre- and post-kidney transplantation.
Main Results:
- ESRD patients show reduced lymphoid cell numbers/function but normal/increased myeloid cells with heightened inflammation.
- Increased proinflammatory T cells and monocytes in ESRD suggest premature immunological aging, acting as cardiovascular risk factors.
- Immune system cellular composition did not normalize post-transplantation, indicating persistent skewing towards myeloid-generating stem cells.
Conclusions:
- Uraemia induces premature immune system aging in ESRD patients, characterized by myeloid cell bias and inflammation.
- This immune aging is associated with increased cardiovascular risk and persists post-transplantation.
- Permanent alterations in hematopoietic stem cells may underlie the persistent immune aging observed in ESRD patients.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Diabetic Nephropathy
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Acute Kidney Injury II: Pathophysiology
